Financial Year |
September 30 2020 |
Monetary Funds |
552,605,798.48 |
Held-for-trading Financial Assets |
-- |
Notes Receivable |
1,625,802.29 |
Accounts Receivable |
246,079,583.82 |
Advances to Suppliers |
10,754,136.06 |
Other Receivables |
24,449,001.15 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
-- |
Inventories |
124,584,659.61 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
-- |
Other Current Assets |
1,840,460.50 |
Total Current Assets |
972,588,420.31 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
-- |
Long-term Equity Investment |
17,821,682.65 |
Investment Properties |
-- |
Fixed Assetes |
7,091,872.48 |
Under-construction Projects |
-- |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
2,735,796.77 |
R&D expenses |
-- |
Goodwill |
-- |
Long-Term Deferred and Prepaid Expenses |
6,911,996.43 |
Deferred Income Tax Assets |
12,641,693.47 |
Other Non-Current Assets |
-- |
Sub-Total of Non-Current Assets |
53,714,291.80 |
Total Assets |
1,026,302,712.11 |
Short-Term Loans |
-- |
Trading Financial liabilities |
-- |
Notes Payable |
-- |
Accounts Payable |
138,240,591.23 |
Accounts Received In Advance |
-- |
Employee Compensation Payable |
25,398,844.09 |
Taxes Payable |
9,074,045.94 |
Interest Payable |
-- |
Dividend Payable |
1,151,440.00 |
Other payables |
6,160,071.54 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
5,000,000.00 |
Other Current Liabilities |
893,775.44 |
Sub-Total of Current Liabilities |
299,743,956.49 |
Long-term Loans |
-- |
Bonds Payable |
-- |
Long-Term Accounts Payable |
-- |
Special Payable |
-- |
Estimatied Liabilities |
-- |
Deferred Income Tax Liabilities |
-- |
Other Non-Current Liabilities |
-- |
Sub-Total of Non-Current Liabilities |
774,292.85 |
Total Liabilities |
300,518,249.34 |
Paid-In Capital(Or Share Stock) |
135,300,000.00 |
Capital Surplus |
338,669,434.51 |
Surplus Reserve |
30,982,116.88 |
LESS:Treasury Stock |
-- |
Undistributed Profits |
211,295,268.41 |
Minority Stockholder's Interest |
11,190,266.10 |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
714,594,196.67 |
Owner's Equity(Stockholder's Equity) |
725,784,462.77 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
1,026,302,712.11 |